BioSpace News Archive

Replica Analytics, an Aetion company, has unveiled a novel approach to use synthetic data for a more accurate assessment of re-identification risks in datasets, to better manage privacy risks and enable greater data sharing in healthcare and other sectors.

NovAccess Global Inc. announced the filing of an application with the U.S. Food and Drug Administration to receive Orphan Drug Designation for TLR-AD1, a vaccine immunotherapy for the treatment of aggressive brain cancers, including glioblastoma and other high grade gliomas.

According to Vision research Reports, the global 3D laparoscopy imaging systems market was surpassed at USD 3.98 billion in 2021 and is expected to hit around USD 6.5 billion by 2030, growing at a CAGR of 5.6% from 2022 to 2030.

KalVista Pharmaceuticals, Inc., a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, announced it will be presenting at the 1st Annual H.C. Wainwright Hereditary Angioedema Conference on Wednesday, July 20, 2022 at 12:00 p.m. ET.

Clene Inc. today reported that it has received a positive opinion for its submission requesting Orphan Drug Designation for CNM-Au8® for the treatment of amyotrophic lateral sclerosis (ALS).

XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, announces submission of a request for “scientific advice review” to the European Medicines Agency (the “EMA”) and more specifically the Committee for Medicinal Products for Human Use (the “CHMP”) regarding the XRx-008 program.

Endotronix, Inc. announced plans to relocate and expand their headquarters in Naperville, Illinois to support the full U.S. commercial launch of its Cordella™ Heart Failure System and Pulmonary Artery Sensor, pending pre-market approval of the sensor by the U.S. Food & Drug Administration.

908 Devices Inc., (Nasdaq: MASS) a pioneer of purpose-built handheld and desktop mass spec devices for chemical and biomolecular analysis, today announced it will report financial results for the second quarter 2022 before market open on Tuesday, August 9, 2022.

ANANDA Scientific Inc ., a research-focused bio-pharmaceutical company, today announced that Dennis Wong , President and CEO of Baxco Pharmaceutical Inc, has been appointed to A NANDA Scientific’s Board of Directors.

Enveric Biosciences , Inc. (NASDAQ: ENVB) (“Enveric” or the “Company”), a neuroscience-focused biotechnology company developing next-generation, psychedelic-inspired mental health medicines, today announced the formation of its Scientific Advisory Board (SAB).